AGP Executive Report
Last update: 7 hours agoRural Health Funding: Arkansas will receive $149.3M in Rural Health Transformation Program grants for 50 projects, from telehealth and psychiatric safe rooms to rural hospital upgrades. Drug Pricing & Pharma Strategy: Pharmaceutical Executive reports the Trump administration is planning new Medicaid drug-pricing deals, while executives weigh uncertainty around Most Favored Nation pricing and upcoming Part B negotiations. Vaccine Demand Spike: India’s flu vaccine demand is surging amid rising H1N1 cases, with at-home vaccination services expanding as supply tightens. Regulatory/Quality Watch: Baxter recalled multiple injectables over possible fiberglass or metal contamination, warning of risks like blockages and tissue injury. Healthcare Costs & Access: A UCLA study finds cancer biosimilars cut monthly costs for insurers and slightly reduce out-of-pocket spending for patients. Big Tech & Youth Mental Health: A whistleblower says Meta’s youth-safety settlement doesn’t meaningfully fix harms, even as states announce major terms and usage limits. Industry Moves: Outlook Therapeutics named a new CFO as it prepares for U.S. commercial launch of LYTENAVA. Compliance & Devices: Health Canada’s Phase II medical device establishment licence updates take effect Dec. 14, aiming to reduce burden and clarify requirements.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
